← Back

Wire · opportunities

Masimo Receives FDA 510(k) Clearance for smartSedLine™ to Advance Brain Health ...

Published

18 November 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at biospace.com →

◆ Verified

Fusion42 · 18 November 2026 · Fusion42 review

Masimo has received FDA 510(k) clearance for its smartSedLine™, an advanced brain function monitoring technology that improves assessment of sedation depth during anesthesia by providing faster and more stable patient state index (PSi) readings, especially under low EEG power conditions.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You can now use FDA-cleared tech that sharpens sedation monitoring during surgery and supports personalised brain care. This gives you an opening to improve patient outcomes, especially for high-risk and elderly patients.

◆ Coverage

1 source · 18 Nov 2026

◆ Related on Wire

◆ Topics

MedtechFDA-clearancebrain-monitoringanesthesiamedtechpatient-care